News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Neil Schneider, ASA, MAAA

Articles by Neil Schneider, ASA, MAAA

Third-Party Validation of Observed Savings From an Oncology Pathways Program

ByBruce A. Feinberg, DO,Scott Milligan, PhD,Joseph Cooper, BS,Winston Wong, PharmD,Daniel Winn, MD,Neil Schneider, ASA, MAAA,Sheamus Parkes, FSA, MAAA,Jeffrey Scott, MD

June 18th 2013

Latest Updated Articles

Third-Party Validation of Observed Savings From an Oncology Pathways Program
June 18th 2013

Trending on AJMC

FDA Expands Finerenone Approval to CKD Associated With Type 1 Diabetes

Twice-Yearly CD19 Therapy Targets MG Root Cause: Richard Nowak, MD, MS

GLP-1 Receptor Agonists Cut Ascites, Mortality in MASH

Hepatitis A Vaccine Prevents 96% of Infections Given Before Exposure

Higher CPAP Adherence Linked With Lower Mortality Risk in OSA